Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer

被引:17
作者
Purrahman, Daryush [1 ]
Mahmoudian-Sani, Mohammad-Reza [1 ,2 ]
Saki, Najmaldin [1 ]
Wojdasiewicz, Piotr [3 ]
Kurkowska-Jastrzebska, Iwona [4 ]
Poniatowski, Lukasz A. [5 ,6 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Thalassemia & Hemoglobinopathy Res Ctr, Hlth Res Inst, Ahvaz, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Golestan Hosp, Clin Res Dev Unit, Ahvaz, Iran
[3] Med Univ Warsaw, Fac Hlth Sci, Dept Biophys Physiol & Pathophysiol, Chalubbiskiego 5, PL-02004 Warsaw, Poland
[4] Inst Psychiat & Neurol, Dept Neurol 2, Sobieskiego 9, PL-02957 Warsaw, Poland
[5] Med Univ Warsaw, Ctr Preclin Res & Technol CePT, Dept Expt & Clin Pharmacol, Banacha 1B, PL-02097 Warsaw, Poland
[6] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Neurosurg, WK Roentgena 5, PL-02781 Warsaw, Poland
关键词
Progranulin; Breast cancer; Biomarker; Metastasis; Cancer drug resistance; GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR; GP88; PROGRANULIN; MESENCHYMAL TRANSITION; TAMOXIFEN RESISTANCE; C-MYC; EXPRESSION; PROMOTES; CELLS; PROLIFERATION;
D O I
10.1016/j.cyto.2022.155803
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer constitute a common type of oncological disease with a highlighted mortality rate. In recent years, researchers have introduced progranulin (PGRN) as an novel potential biomarker and associated its function with higher risk factor for development of breast cancer. The present review article collects evidence on the association of PGRN with clinicopathological features and drug resistance in the patients with breast cancer. The results of this study suggested the use of routine determination of PGRN in the clinic as a reliable biomarker for screening people at high risk or as early indication of breast cancer. Targeting PGRN and its associated signaling pathways and receptors, such as sortilin (SORT1), could also cover a novel therapeutic strategy in the breast cancer.
引用
收藏
页数:9
相关论文
共 109 条
[71]   Angiogenesis in cancer [J].
Nishida, Naoyo ;
Yano, Hirohisa ;
Nishida, Takashi ;
Kamura, Toshiharu ;
Kojiro, Masamichi .
VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (03) :213-219
[72]   HDL/Apolipoprotein A-I Binds to Macrophage-Derived Progranulin and Suppresses its Conversion into Proinflammatory Granulins [J].
Okura, Hanayuki ;
Yamashita, Shizuya ;
Ohama, Tohru ;
Saga, Ayami ;
Yamamoto-Kakuta, Aya ;
Hamada, Yoko ;
Sougawa, Nagako ;
Ohyama, Reiko ;
Sawa, Yoshiki ;
Matsuyama, Akifumi .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (06) :568-577
[73]  
Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275
[74]   The Evolution of the Secreted Regulatory Protein Progranulin [J].
Palfree, Roger G. E. ;
Bennett, Hugh P. J. ;
Bateman, Andrew .
PLOS ONE, 2015, 10 (08)
[75]   Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling [J].
Park, Boyoun ;
Buti, Ludovico ;
Lee, Sungwook ;
Matsuwaki, Takashi ;
Spooner, Eric ;
Brinkmann, Melanie M. ;
Nishihara, Masugi ;
Ploegh, Hidde L. .
IMMUNITY, 2011, 34 (04) :505-513
[76]  
PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073
[77]   The prognostic relevance and expression of progranulin in adult patients with acute myeloid leukemia [J].
Qin, Jiajia ;
Huang, Shigao ;
Qian, Jiao ;
Xu, Chunyan ;
Li, Shixiao ;
Yu, Sufei ;
Yan, Haixi ;
Wu, Mingjiao ;
Chen, Jiaxi ;
Ren, Hanxing ;
Peng, Minfei .
MEDICINE, 2020, 99 (01)
[78]   Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion [J].
Rhost, Sara ;
Hughes, Eamon ;
Harrison, Hannah ;
Rafnsdottir, Svanheidur ;
Jacobsson, Hanna ;
Gregersson, Pernilla ;
Magnusson, Ylva ;
Fitzpatrick, Paul ;
Andersson, Daniel ;
Berger, Karoline ;
Stahlberg, Anders ;
Landberg, Goran .
BREAST CANCER RESEARCH, 2018, 20
[79]   Tumor-associated macrophages: role in cancer development and therapeutic implications [J].
Salmaninejad, Arash ;
Valilou, Saeed Farajzadeh ;
Soltani, Arash ;
Ahmadi, Sepideh ;
Abarghan, Yousef Jafari ;
Rosengren, Rhonda J. ;
Sahebkar, Amirhossein .
CELLULAR ONCOLOGY, 2019, 42 (05) :591-608
[80]  
Saqib Uzma, 2018, Oncotarget, V9, P17937, DOI 10.18632/oncotarget.24788